Literature DB >> 23277804

Disseminated fusariosis in a bone marrow transplant patient.

Debora Braga De Pinho1, Louise Leal Fernandes, Maria Da Gloria Carvalho Barreiros, Leonardo Pereira Quintella, Celso Tavares Sodré, Marcia Ramos-E-Silva.   

Abstract

The authors present a case report involving an immunocompromised patient with fusariosis, an often fatal fungal infection in this group of patients. This mycosis needs to be recognized and treated in the initial phases, although this does not guarantee improvement.

Entities:  

Year:  2012        PMID： 23277804      PMCID： PMC3533322     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN： 1941-2789


  8 in total

1.  A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B.

Authors:  Dominik Selleslag
Journal:  Acta Biomed       Date:  2006

Review 2.  Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management.

Authors:  E I Boutati; E J Anaissie
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

3.  The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients: a single institution experience over 10 years.

Authors:  M O Musa; A Al Eisa; M Halim; E Sahovic; M Gyger; N Chaudhri; F Al Mohareb; P Seth; M Aslam; M Aljurf
Journal:  Br J Haematol       Date:  2000-03       Impact factor: 6.998

4.  Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B.

Authors:  Marta Stanzani; Nicola Vianelli; Giuseppe Bandini; Stefania Paolini; Mario Arpinati; Francesca Bonifazi; Benedetta Giannini; Claudio Agostinelli; Michele Baccarani; Paolo Ricci
Journal:  J Infect       Date:  2006-04-11       Impact factor: 6.072

Review 5.  Treating disseminated fusariosis: amphotericin B, voriconazole or both?

Authors:  Dora Y Ho; Jason D Lee; Fernando Rosso; Jose G Montoya
Journal:  Mycoses       Date:  2007-05       Impact factor: 4.377

6.  Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.

Authors:  Sophie Consigny; Nathalie Dhedin; Annick Datry; Sylvain Choquet; Véronique Leblond; Olivier Chosidow
Journal:  Clin Infect Dis       Date:  2003-07-09       Impact factor: 9.079

Review 7.  Human fusariosis.

Authors:  M C Dignani; E Anaissie
Journal:  Clin Microbiol Infect       Date:  2004-03       Impact factor: 8.067

Review 8.  Fusarium infections in immunocompromised patients.

Authors:  Marcio Nucci; Elias Anaissie
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132
  8 in total
  2 in total

1.  Fusarium napiforme systemic infection: case report with molecular characterization and antifungal susceptibility tests.

Authors:  Marcela de Souza; Tetsuhiro Matsuzawa; Luzia Lyra; Ariane Fidelis Busso-Lopes; Tohru Gonoi; Angélica Zaninele Schreiber; Katsuhiko Kamei; Maria Luiza Moretti; Plínio Trabasso
Journal:  Springerplus       Date:  2014-08-30

2.  Disseminated Fusariosis in a Patient With Acute Myeloid Leukemia: A Case Report.

Authors:  Navdeep Dehal; David Quimby
Journal:  Cureus       Date:  2019-10-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.